NFA
VRTX icon

Nuveen Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Nuveen Fund Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,365
Closed -$232K – 161
2018
Q2 		$232K Sell
1,365
-2,934
-68% -$455K 0.29% 137
2018
Q1 		$701K Sell
4,299
-307
-7% -$50.1K 0.32% 92
2017
Q4 		$690K Sell
4,606
-4,870
-51% -$721K 0.2% 139
2017
Q3 		$1.44M Sell
9,476
-1,734
-15% -$261K 0.29% 109
2017
Q2 		$1.45M Sell
11,210
-8,838
-44% -$1.06M 0.23% 138
2017
Q1 		$2.19M Sell
20,048
-3,704
-16% -$326K 0.29% 122
2016
Q4 		$1.75M Sell
23,752
-5,465
-19% -$445K 0.25% 128
2016
Q3 		$2.55M Sell
29,217
-655
-2% -$61.9K 0.36% 97
2016
Q2 		$2.57M Buy
+29,872
New +$2.58M 0.4% 84

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return